# Verona Pharma plc

Verona Pharma plc is a company headquartered in London, United Kingdom.

## Company overview

- **Legal name:** Verona Pharma plc
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** London, United Kingdom
- **Incorporated in:** X0
- **Fiscal year end:** December 31
- **SEC CIK:** 0001657312

## About

Verona Pharma plc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001657312, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-02-27, it reported annual revenue of USD 42,279,000; net income of USD -173,418,000; total assets of USD 474,242,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $42.3M (USD 42,279,000)
- **Net income:** -$173.4M (USD -173,418,000)
- **Total assets:** $474.2M (USD 474,242,000)
- **Cash and equivalents:** $399.8M (USD 399,757,000)
- **Operating cash flow:** -$122.2M (USD -122,203,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$54.4M (USD -54,369,000)
- **Total assets:** $308.1M (USD 308,124,000)
- **Cash and equivalents:** $271.8M (USD 271,772,000)
- **Operating cash flow:** -$50.2M (USD -50,222,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $458,000 (USD 458,000)
- **Net income:** -$68.7M (USD -68,701,000)
- **Total assets:** $259.5M (USD 259,468,000)
- **Cash and equivalents:** $227.8M (USD 227,827,000)
- **Operating cash flow:** -$59.9M (USD -59,862,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $40.0M (USD 40,000,000)
- **Net income:** -$55.6M (USD -55,569,000)
- **Total assets:** $186.6M (USD 186,587,000)
- **Cash and equivalents:** $148.4M (USD 148,380,000)
- **Operating cash flow:** -$33.3M (USD -33,254,000)

## Recent SEC filings

- Form 8-K — filed 2025-10-07 — period 2025-10-07 — FORM 8-K
- Form 8-K — filed 2025-09-24 — period 2025-09-24 — FORM 8-K
- Form 8-K — filed 2025-09-09 — period 2025-09-05 — FORM 8-K
- Form 10-Q — filed 2025-08-06 — period 2025-06-30 — 10-Q
- Form 8-K — filed 2025-07-09 — period 2025-07-08 — FORM 8-K
- Form 10-Q — filed 2025-04-29 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-04-29 — period 2025-04-29 — 8-K
- Form 8-K — filed 2025-04-25 — period 2025-04-24 — FORM 8-K
- Form 8-K — filed 2025-03-28 — period 2025-03-25 — FORM 8-K
- Form DEF 14A — filed 2025-03-18 — period 2025-04-24 — FORM DEF14A
- Form 10-K — filed 2025-02-27 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-02-27 — period 2025-02-27 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/verona-pharma-plc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology